New drug curbs Alzheimer's and slows down ageing

Researchers have tested a promising agent that can prevent the formation of harmful protein clumps in the brain. These protein clumps, known as amyloid plaques, play a major role in Alzheimer's. In experiments with mice, the agent ensured that nerve cells remained healthy for longer and that less amyloid accumulated in the brain.

In addition, the mice that received the treatment also appeared to have better heart health. Furthermore, the treatment delayed some signs of ageing, which offers additional hope for a broader approach to age-related diseases. This potentially opens up new avenues for the treatment of dementia and age-related disorders.

Alzheimer's often develops due to the accumulation of misfolded proteins that damage brain cells. By blocking these processes early, scientists hope to be able to combat the disease more effectively. Although these findings still come from animal trials, it is an important step towards potential new medicines for humans.

Healthy ageing increasingly also means preventing such diseases that affect the memory. Scientific breakthroughs like these can contribute to a better quality of life in older age by helping to keep the brain and heart young and vital for longer.

Source: Original article